Alopecia areata, a nonscarring autoimmune-based hair disorder that has a lifetime incidence rate of up to about 2%, may affect psychological, emotional, and social realms.
If not properly monitored and treated, this adverse event can manifest into torsades de pointes, leading to sudden cardiac death.
This nonopioid veterinary tranquilizer, which is not approved for human use, is linked to an alarming number of drug overdose deaths across the United States.
Newer drugs are more targeted than standard agents, but their incorporation into treatment regimens is challenging because of the risk of cardiovascular and infectious adverse events.
This agent recently achieved an additional indication to reduce myocardial infarction, stroke, coronary revascularization, and cardiovascular death risk in adult patients with ASCVD.